Maiwei biology: it is estimated that the net loss in 2021 will be 666 million yuan - 782 million yuan
Maiwei biological announced that the company expects a net loss of 666 million yuan to 782 million yuan in 2021. During the reporting period, all products under research of the company were in the research and development stage, and commercial sales had not been carried out, and the sales revenue of the company's products had not been realized. During the reporting period, the company's main business income was mainly technical service income.
This text is a result of machine translation.
Related companies：
In-depth
Jun 27, 2022 05:00 PM
May 02, 2022 07:50 PM
Apr 25, 2022 01:02 PM
Research
Consumer StaplesChina’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Apr 19, 2022 11:38 PM
Briefing Jun 27, 2022 07:49 AM
· Technology
New energy players flocking to carbon nanotube materials to grab high growth single products
Briefing Jun 20, 2022 12:24 PM
· Automotive
Analysis of midday limit on June 20
Briefing Jun 17, 2022 07:14 AM
· Automotive
Transformation and acceleration several auto companies stated that they would stop producing fuel vehicles
Automotive
With the Intervention of Investigation Team, BYD C.China factory suspends the production t
The BYD pollution case has ushered in a new development. With the official intervention of the government investigation team, the factory suspected to stop production, and the production and delivery of the involved models may be affected
May 16, 2022 12:32 PM
Briefing Jun 12, 2022 07:03 PM
· Automotive
Longji machinery: BYD's new energy vehicles and other models are supported by the company, accounting for more than 85%
See more
Read next
In-depth
In-depth
Technology
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
In-depth
Healthcare
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.